Gpr88 Deletion Impacts Motivational Control Without Overt Disruptions to Striatal Dopamine

Autor: Spark, Daisy L. ^{a, b, c, 1}, Vermeulen, Michela H. ^{a, 1}, de la Fuente Gonzalez, Rocío A. ^{a, b, c}, Hatzipantelis, Cassandra J. ^d, Rueda, Patricia ^a, Sepehrizadeh, Tara ^e, De Veer, Michael ^e, Mannoury la Cour, Clotilde ^f, Fornito, Alex ^g, Langiu, Monica ^{a, b, 2}, Stewart, Gregory D. ^{a, b, c, 2, ∗}, Nithianantharajah, Jess ^{h, 2, ∗}, Langmead, Christopher J. ^{a, b, c, 2}

Publikováno v: In Biological Psychiatry Global Open Science October 2023 3(4):1053-1061

Gpr88 Deletion Impacts Motivational Control Without Overt Disruptions to Striatal Dopamine.

Autor: Spark DL; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Vermeulen MH; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., de la Fuente Gonzalez RA; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Hatzipantelis CJ; Olson Lab, Department of Chemistry, University of California, Davis, California., Rueda P; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Sepehrizadeh T; Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia., De Veer M; Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia., Mannoury la Cour C; Neuroscience and Inflammation Therapeutic Area, Institut de Recherches Servier, Suresnes, France., Fornito A; Turner Institute for Brain and Mental Health, Monash Biomedical Imaging, and School of Psychological Sciences, Monash University, Clayton, Victoria, Australia., Langiu M; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Stewart GD; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Nithianantharajah J; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Langmead CJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

Publikováno v: Biological psychiatry global open science [Biol Psychiatry Glob Open Sci] 2022 Nov 11; Vol. 3 (4), pp. 1053-1061. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2023).